A team of researchers found that DNA damaged by the widely used chemotherapy drug cisplatin is mostly good as new in noncancerous tissue within two circadian cycles, or two days. The results could inform the development of chronochemotherapies — strategies aimed at administering chemotherapy drugs at times that maximize tumor damage while minimizing side effects.